Search
Sumario de resultados
TIpos de contenido
Fecha
-
NewORYZON presents the final data from PORTICO, a global Phase IIb vafidemstat trial in Borde...
Company presented the data to the FDA and discussed potential registrational Phase III vafidemstat study for the treatment of BPD at a recent End-of-Phase II meeting.
-
NewAseBio highlights the main regulatory challenges faced by the Spanish biotechnology sector...
Sector-specific regulations, such as the revision of European pharmaceutical legislation, the IVDR and MDR Regulations, and the Health Technology Assessment Regulation, significantly impact
-
NewBiotechnology plays a crucial role in the latest advances against Alzheimer's
Biotechnology is behind every medication being tested and eventually approved, making its contribution the key factor that has enabled improvements in treatments in recent years.
-
Press releaseBiotechnology plays a crucial role in the latest advances against Alzheimer's
Nearly two decades ago, the first group of compounds to treat Alzheimer's disease were approved, but they do not stop the progression of the neurodegenerative process nor restore the neuronal damage
-
NewBIOSPAIN 2023 takes bronze in the “Best Congress” category at the XIX edition of the event...
The eventoplus Awards are the top accolades for the events and meetings sector in Spain and Portugal, and the award ceremony took place on September 17.
-
OfferSr. Project Manager
-
NewZETA & INOSIM: Partnering for Industry 4.0 Success in Spain
ZETA, a leading provider of end-to-end solutions for the biopharma and pharma industry, has announced the acquisition of a majority stake in INOSIM Software GmbH, a German company that specializes in
-
NewBiorizon Biotech and its Trietech© technology, world leader in microalgae-based agricultu...
Biorizon Biotech has become a global leader in agricultural biotechnology and is renowned for its innovative microalgae-based Trietech© technology. Since it was founded, the company has transformed
-
NewNatac starts up the largest omega-3 production plant in Spain
The factory, which has a production capacity of up to 10,000 tonnes per year, is equipped with state-of-the-art technology for processing omega-3 oil. The first oil production tests began in July and
-
NewThe Comparative Medicine and Bioimage Centre of Catalonia celebrates its fifth anniversary
Prominent researchers and health professionals shared success stories developed at the centre and discussed the future of fields such as personalised medicine, bioimaging, and robotic surgery.
-
NewRevolutionary CAR-T Cell Therapies: A New Era in Cancer Treatment
Promega's contribution to the development and verification of genetically modified CAR-T cells is driving innovation in cancer immunotherapy.
-
NewAMSbiopharma launches an innovation plan to strengthen its position in the biopharmaceutic...
AMSbiopharma’s Innovation Plan goes beyond improving internal processes, adopting a comprehensive approach that encompasses innovation in services, technology, and organization.
-
NewWe analyze the challenges and opportunities for promoting and developing biotechnological ...
Proposals such as improving the financing environment for disruptive innovation, startups, and expanding companies, or maximizing the impact of the European Health Data Space, among others, are
-
CompanySIMBIONTE
-
NewBiotechnology revolutionizes the diagnosis and treatment of lymphoma, the seventh most com...
It is estimated that in 2024, around 12,400 new cases of lymphoma will be diagnosed in Spain, the majority (approximately 85%) being non-Hodgkin.
-
Press releaseBiotechnology revolutionizes the diagnosis and treatment of lymphoma, the seventh most com...
There are more than 40 types of lymphomas that can generally be grouped into two major subgroups: Hodgkin lymphoma and non-Hodgkin lymphoma. It is estimated that in 2024, around 12,400 new cases of
-
NewBiotechnology, at the forefront of the fight against sepsis, one of the world's most serio...
The use of artificial intelligence or an innovative approach focused on measuring NLRP3 inflammasome activation in monocytes ex vivo are examples of the latest advancements against sepsis.
-
Press releaseBiotechnology, at the forefront of the fight against sepsis, one of the world's most serio...
Sepsis is a potentially life-threatening condition that occurs when the body's immune system reacts in an extreme way to an infection, causing organ dysfunction. 22% of sepsis survivors who have
-
New#NewAseBioMember | “AseBio, for our small biotech, is a platform that offers a multitude o...
Meet Telomere Therapeutics, our new member. We spoke with Ana Margarita Maldonado, CMC & Regulatory Manager.
-
NewORYZON receives “Intention to grant” communication for patent relating to the use of vafid...
The intention to grant is a formal communication from the EPO in which it indicates that the patent application has reached the status where it is allowed for issuance as a patent.
-
NewBiological Sex Differences in Health: Challenges and Opportunities for Personalised Medici...
Biological sex should be considered as a variable in all health-related biomedical research.